A carregar...
CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor α in Human Liver
Human cytochrome P450 (CYP) 2C enzymes metabolize ∼30% of clinically prescribed drugs and various environmental chemicals. CYP2C8, an important member of this subfamily, metabolizes the anticancer drug paclitaxel, certain antidiabetic drugs, and endogenous substrates, including arachidonic acid, to...
Na minha lista:
| Publicado no: | Mol Pharmacol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The American Society for Pharmacology and Experimental Therapeutics
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4702104/ https://ncbi.nlm.nih.gov/pubmed/26467040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.100255 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|